Cohort maintenance and comparability in a pharmacoepidemiologic study using a commercial consumer panel to recruit comparators

Pharmacoepidemiology and Drug Safety

Volumn 5, Issue 4, 1996, Pages 207-214

  Gardner, Jacqueline S ^a   Szpunar, Cheryl A ^b   O'Connell, Martin J ^b   Facklam, David P ^c   Mariano, Joseph P ^d   Borden, E Keith ^d   Leinweber, Frank B ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PFIZER INC   (United States)

^c ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^d NFO Research Inc ^*

^e NFO Research Inc   (United States)

Author keywords

Androgenetic alopecia; Cohort studies; Pharmacoepidemiology; Postmarketing surveillance; Prescription drugs

Indexed keywords

MINOXIDIL;

ARTICLE; DEATH; DEMOGRAPHY; DRUG USE; HOSPITALIZATION; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029807267     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199607)5:4<207::AID-PDS190>3.0.CO;2-I     Document Type: Article

References (16)

1. Kosman, M. E. Evaluation of a new antihypertensive agent. Minoxidil. Journal of the American Medical Association 1980; 244: 73-75.
2. Johnson, B. F., Black, H. R., Beckner, R., et al. A comparison of minoxidil and hydralazine in non-azotemic hypertensives. Journal of Hypertension 1983; 1: 103-107.
3. Houston, M. C., McChesney, J. A. and Chatterjee, K. Pericardial effusion associated with minoxidil therapy. Archives of Internal Medicine 1981; 141: 69-71.
4. Gardner, J. S., Szpunar, C. A., O'Connell, M. J., et al. Use of a commercial consumer panel to recruit a comparator cohort for a pharmacoepidemiologic study. Pharmacoepidemiology and Drug Safety. 1996; 5: 165-172.
5. Fleiss, J. L. Statistical Methods for Rates and Proportions. John Wiley & Sons, New York, 1973.
6. Spry, V. M., Hovell, M. F., Sallis, J. G., et al. Recruiting survey respondents to mailed surveys: controlled trials of incentives and prompts. American Journal of Epidemiology 1989; 130: 166-172.
7. Kramer, F. M., Jeffery, R. W. and Snell, M. K. Monetary incentives to improve follow-up data collection. Psychological Reports 1986; 58: 739-742.
8. Stampfer, M. J., Willett, W. C., Speizer, F. E., et al. Test of the National Death Index. American Journal of Epidemiology 1984; 119: 837-839.
9. Stampfer, M. J., Willett, W. C., Colditz, G. A., et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. New England Journal of Medicine 1985; 313: 1044-1049.
10. Gillum, R. F. and Feinleib, M. Cardiovascular disease in the United States: Mortality, prevalence, and incidence. In: Prognosis and Risk Assessment in Cardiovascular Disease. Kapoor, A. S. and Singh, B. N. (Eds) Churchill Livingstone Inc., New York, 1993.
11. Makuc, D. M., Feldman, J. J. and Gillum, R. F. Educational differentials in heart disease incidence and case-fatality rates in a national sample. American Journal of Epidemiology 1988; 128: 892.
12. Cutter, G. R., Burke, G. L., Dyer, A. R., et al. Cardiovascular risk factors in young adults: the CARDIA baseline monograph. Controlled Clinical Trials 1991; 12: 1S-77S.
13. Wilson, P. W. F., Christiansen, J. C., Anderson, K. M. and Kannel, W. B. Impact of national guidelines for cholestrol risk factor screening: The Framingham Offspring Study. Journal of the American Medical Association 1989; 262: 41-44.
14. Hamilton, J. B. Patterned loss of hair in man: types and incidence. Annals of the New York Academy of Sciences 1951; 53: 708-728.
15. Norwood, O. T. Male pattern baldness: classification and incidence. Southern Medical Journal 1975; 68: 1359-1365.
16. Lesko, S. M., Rosenberg, L. and Shapiro, S. A case-control study of baldness in relation to myocardial infarction in men. Journal of the American Medical Association 1993; 269: 998-1003.